Protective effect of edaravone on rat testis after valproic acid treatment

Basit Öğe Kaydı
dc.authorid0000-0002-6183-5015
dc.contributor.authorÇelik, Çağrı
dc.contributor.authorBayrak, Bertan Boran
dc.contributor.authorHacıhasanoğlu Çakmak, Neziha
dc.contributor.authorYanardağ, Refiye
dc.date.accessioned2022-01-10T07:13:47Z
dc.date.available2022-01-10T07:13:47Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Hizmetleri Meslek Yüksekokulu, Eczane Hizmetleri Ana Bilim Dalı
dc.description.abstractValproic acid n-dipropyl-acetic acid, VPA) is a medication used as anticonvulsant in the treatment of bipolar disorder, and for migraine prophylaxis. Long-term use of VPA is known to trigger reproductive impairment, which is mediated by elevation of testicular oxidative stress. Edaravone is used in the treatment of cerebrovascular diseases. It can diffuse into many disease-affected organs, thus shows protective effects in numerous tissues including the heart, lung, and testis. The main goal of the present study was to determine the possible protective role of edaravone against VPA-induced oxidative testicular injury. Male Sprague Dawley rats were assigned into four groups. Control rats; rats given only edaravone (30 mg/kg/day); rats given only VPA (500 mg/kg/day); rats given VPA+edaravone for seven days. Edaravone and VPA were applied intraperitoneally. After eight days, testicular tissues were taken from rats. There was a statistically significant increase in the levels of reduced glutathione, lipid peroxidation, reactive oxygen species, total oxidant status, oxidative stress index, and DNA contents as well as catalase, superoxide dismutase, glutathione-related enzymes, gamma-glutamyl transferase, acid and alkaline phosphatases, lactate dehydrogenase, myeloperoxidase and sorbitol dehydrogenase activities in VPA group. More so, advanced oxidized protein products, protein carbonyl, and nitric oxide levels were also significantly increased in VPA group. Activities of glucose-6-phosphate dehydrogenase and sodium/potassium ATPase and total antioxidant status levels remarkably decreased in VPA given group. Treatment with edaravone to VPA group significantly reverted these alterations. These findings demonstrate that administration of edaravone has a beneficial effect against testicular injury in VPA-induced oxidative stress.
dc.description.sponsorshipIstanbul University-Cerrahpasa Scientific Research Projects Uniten_US
dc.identifier.citationÇelik, Ç., Bayrak, B. B., Hacıhasanoğlu Çakmak, N. ve Yanardağ, R. (2022). Protective effect of edaravone on rat testis after valproic acid treatment. Journal of Research in Pharmacy, 26(1), 52-62. https://doi.org/10.29228/jrp.103
dc.identifier.doi10.29228/jrp.103
dc.identifier.endpage62
dc.identifier.issn2630-6344
dc.identifier.issue1
dc.identifier.scopusqualityQ3
dc.identifier.startpage52
dc.identifier.urihttps://doi.org/10.29228/jrp.103
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8789
dc.identifier.volume26
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMarmara University
dc.relation.ispartofJournal of Research in Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEdaravone
dc.subjectTestis Injury
dc.subjectValproic Acid
dc.subjectOxidative Stress Parameters
dc.subjectAntioxidant Enzymes
dc.titleProtective effect of edaravone on rat testis after valproic acid treatment
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Cakmak-Neziha-2022.pdf
Boyut:
764.12 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu